Legal and accounting software specialist Tikit (TIK) has issued a solid trading statement in which it predicts its full year results will be in line with market expectations.
Buoyed by strong demand for its own products, the AIM counter has maintained its operating margins of 17.1 per cent through the second half of 2011. In addition, Tikit is enjoying strong cash generation so this help boost its cash balance - £4.1 million at the interim stage.
Tikit has secured a healthy pipeline of implementation work, which combined with its focus on recurring revenue provide a solid backdrop for the current year. House broker Charles Stanley predicts 2011 pre-tax profits of £4.3 million and EPS of 21.3p.
The shares are up 7p to 293.5p as the market warms to the latest update from Tikit. Further news on current trading will be released in March when Tikit issues its full-year results. We last urged readers to buy the shares in Growth Company Investor in September at 266.5p, so the rally since then is pleasing. Hold on.
The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info
Latest small-cap and growth company news
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
One View listed on AIM via a reverse takeover back in March. It has developed software that provides retailers with a combined view of their customers history in both online and in-store shopping channels. This sort of digital engagement is a big opportunity for retailers to boost their sales.
Angle is making good progress with its ‘Parsortix’ system which uses a precision-etched cassette to ‘sieve’ patient blood samples and capture cancerous tumour cells. The first major trial is now underway in ovarian cancer, led by the University of Vienna.
Transportation software specialist Tracsis has won a significant contract in the US. This looks like it could be a breakthrough which opens up the vast North American railroad market to this Leeds based company.
ScS Group confirms it hasn't seen a slowdown in demand post-Brexit. Momentum has continued since the update in early June, with like-for-like sales order intake of 14.8 per cent for the first financial year ending in July.